Tech Company Financing Transactions
Carmenta Bioscience Funding Round
Carmenta Bioscience, operating out of Palo Alto, secured $2 million from private investors.
Transaction Overview
Company Name
Announced On
8/8/2013
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Seed
Investors
private investors (Camille Samuels)
Proceeds Purpose
Proceeds from the financing will support development and commercialization of a new, proprietary test to better diagnose and predict preeclampsia in pregnant women.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
4240 Wilkie Way
Palo Alto, CA 94306
USA
Palo Alto, CA 94306
USA
Phone
Website
Email Address
Overview
Carmenta Bioscience, Inc., is a privately held medical technology company dedicated to improving maternal and fetal health. Spun-out of Stanford University School of Medicine in 2012, Carmenta Bioscience is currently developing a highly accurate, serum-based diagnostic test for preeclampsia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Cooper
Chief Scientific Officer
Atul Butte
Co-Founder
Bruce Ling
Browse more venture capital transactions:
Prev: 8/8/2013: Innography venture capital transaction
Next: 8/8/2013: Kareo venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs